Wenzel Spine Announces FDA Clearance to Include Allograft with the VariLift® Product Family
We are pleased to have recently received clearance from the U.S. Food and Drug Administration (FDA) to market our Expandable Stand-Alone VariLift® systems for use with allograft.
Wenzel Spine’s VariLift® Platforms Now Provide the Broadest Clearance of an Expandable Interbody Fusion Device on the Market.
When expanded, the large fenestrations of our VariLift® devices allow for maximum bone to graft contact as well as overpacking the disc space with graft material post implantation and expansion. This new FDA clearance will give surgeons more options in sourcing the graft tissue that meets their patients specific needs. Check out the video below to see the VariLift®-LX graft chamber in action.
Read more